Skip to content

Anti-Human IgG Serum

by Diagnostica, Inc. United States 510(k)

510(k) K791281

Product code DEW

Overview

This device is an Antigen, Antiserum, Control (per FDA classification DEW) designed for immunochemical testing. It is a reagent used to detect and quantify human Immunoglobulin G (IgG) in plasma or serum samples, aiding in the diagnosis of conditions associated with abnormal IgG levels, such as autoimmune disorders or immunodeficiencies.

The Anti-Human IgG Serum is supplied as a reagent for in vitro diagnostic use, intended for laboratory settings. It is classified as a Class II device under FDA regulations (866.5510) and holds a Traditional 510(k) clearance (K791281) from the FDA, granted in 1979. No specific sterility or single-use/reusable designation is provided in the data, though it is typically used in controlled laboratory environments for precise diagnostic applications.

Summary written by AI from registry data, 19 Sep 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK791281 Date27 Nov 1979ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 6 Oct 2026)

Specification

510(k) · synced 6 Oct 2026

510(k) Number
FDA Product Code
DEW
Device Class
Class II
Regulation
21 CFR Part 866.5510
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Other devices from Diagnostica, Inc.

See all devices from Diagnostica, Inc. →

Questions

  • What is the Anti-Human IgG Serum used for in clinical settings?

    The Anti-Human IgG Serum is designed for immunochemical testing in laboratory settings to detect and quantify human Immunoglobulin G (IgG) in plasma or serum samples. This helps diagnose conditions linked to abnormal IgG levels, such as autoimmune disorders or immunodeficiencies, by providing a reagent for precise diagnostic analysis.

  • Is this product intended for single-use or can it be reused?

    The provided data does not explicitly state whether the Anti-Human IgG Serum is single-use or reusable. However, since it is classified as a reagent for in vitro diagnostic use in controlled laboratory environments, it is typically handled under strict protocols to ensure accuracy and sterility, which often aligns with single-use practices for diagnostic reagents.

  • What regulatory pathway was followed for FDA clearance of this device?

    The Anti-Human IgG Serum received a Traditional 510(k) clearance (K791281) from the FDA in 1979, demonstrating it was determined to be *substantially equivalent* to a legally marketed predicate device. The clearance was granted under the product code DEW (Antigen, Antiserum, Control) and falls under FDA classification 866.5510, which categorizes it as a Class II device.

  • How is the Anti-Human IgG Serum supplied, and what should be considered for storage?

    The data does not specify the exact form of supply (e.g., vial size, concentration, or packaging), but as a reagent for laboratory use, it is likely supplied in sterile, pre-measured aliquots or concentrated forms. Since it is used in controlled settings, storage should follow standard laboratory protocols for reagents—typically at recommended temperatures (often refrigerated or frozen) to maintain stability and prevent degradation until use.

Properties & raw data

Show properties, registry sources and raw records

Sources (1)

  • FDA 510(k) K791281 24 fields · synced 6 Oct 2026